Skip to content

Clinical trials

Terminated Non-alcoholic Fatty Liver Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Terminated Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20151
20162
20174
20191
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Novartis Pharmaceuticals2
Tobira Therapeutics, Inc.2
Alnylam Pharmaceuticals1
Bristol-Myers Squibb1
Galectin Therapeutics Inc.1
Genentech, Inc.1
Genfit1
GlaxoSmithKline1
Intercept Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease14
Fibrosis2
Liver Cirrhosis2
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Digestive System Diseases1
Esophageal and Gastric Varices1
Fatty Liver1
HIV Infections1
Hepatitis B1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.